Carnival of Biotechnology
Welcome to the August 2007 edition of Carnival of Biotechnology. Industry Trends Singapore-based ES Cell International, the company that was […]
Welcome to the August 2007 edition of Carnival of Biotechnology. Industry Trends Singapore-based ES Cell International, the company that was […]
Guest content Contributed by Jayme Norrie, Chief Strategic Officer, Incite World From what we have experienced, angel investors are shoring
Expanding the bandwidth of life science investments: Increasing investment viability Read Post »
Guest content contributed by Agnes Shanley, Editor in Chief, Pharmaceutical Manufacturing Every day we read about severe shortages of skilled
A guest editorial from Emil Ciurczak, Contributing Editor, PharmaManufacturing.com While reading a trade magazine recently, I was struck with the
`Til Death Do Us Part, But First, the Pre-Nup: Why CAPA Needs to Evolve Read Post »
A common retort in the debate over drug reimportation is “Where are the dead Canadians?” If the FDA deems that
Drug reimportation: Where are the dead Canadians? Read Post »
CnnMoney has a cool story on a mother who was motivated to start a biotech company to develop a better
Starting a biotechnology company to treat a child Read Post »
Google’s posted more details on Google Health, including the announcement of their advisory board. Note that the comments to Google’s
Welcome to the June 25th 2007 edition of Carnival of Biotechnology. Finance and business development BusinessFund.com has a great post
I’ll be in Toronto from July 5th-8th. Wanna meet up for coffee? Drop me a line.
I’ve been trying to elucidate Google’s rumored healthcare plans for quite some time now. Google’s plans are outlined in these
Google's healthcare ambitions — the ultimate second opinion Read Post »